Etiology and clinical spectrum of constipation in Indian children

Vikrant Khanna1, Ujjal Poddar, Surender Kumar Yachha

  • 1Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

Indian Pediatrics
|May 11, 2010
PubMed

Insights

Functional constipation is the most common cause of childhood constipation in India. Key indicators like delayed meconium passage and abdominal distension suggest organic causes, differentiating them from functional constipation.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Pediatrics

Background:

  • Constipation is a common pediatric issue with varied etiologies.
  • Differentiating functional from organic constipation is crucial for appropriate management.

Purpose of the Study:

  • To investigate the causes, clinical features, and outcomes of constipation in children.
  • To identify distinguishing factors between functional and organic constipation.

Main Methods:

  • Retrospective chart review of 137 children diagnosed with constipation between 2001 and 2006.
  • Defined functional constipation by absence of organic pathology; organic constipation included cases with identified causes.
  • Lactulose and polyethylene glycol were used for treatment in functional constipation.

Main Results:

  • 85% of children had functional constipation; 15% had organic disorders, including Hirschsprung's disease (6%).
  • Organic constipation was associated with delayed meconium passage (50% vs 1.7%), early onset symptoms (40% vs 1.7%), and abdominal distension (50% vs 5%).
  • Functional constipation commonly presented with fecal impaction (69%), straining (35%), withholding behavior (27.4%), and fecal incontinence (30.8%). 95% of functional cases responded to laxatives.

Conclusions:

  • Functional constipation is the predominant form in Indian children.
  • Delayed meconium passage, abdominal distension, and lack of fecal impaction are indicators of organic constipation.
  • Early identification of organic causes is vital for timely intervention.
Abstract

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...